Imperial College London
Alternate

ProfessorRichardNicholas

Faculty of Medicine, Department of Brain Sciences

Professor of Practice (Neurology)
 
 
 
//

Contact

 

r.nicholas

 
 
//

Location

 

12L12CLab BlockCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Gallagher:2018,
author = {Gallagher, P and McGuigan, C and Nicholas, R and Hobart, J and Ford, H and Petheram, K and Sharrack, B and Robertson, N and Mazibrada, G and Scolding, N and Wilson, M and Pearson, O and Jones, J and Overell, J},
pages = {99--100},
publisher = {SAGE PUBLICATIONS LTD},
title = {Alemtuzumab after natalizumab SWitch in evolving rapidly severe multiple sclerosis (ANSWERS MS): long-term UK & Ireland experience.},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446861400151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Gallagher,P
AU  - McGuigan,C
AU  - Nicholas,R
AU  - Hobart,J
AU  - Ford,H
AU  - Petheram,K
AU  - Sharrack,B
AU  - Robertson,N
AU  - Mazibrada,G
AU  - Scolding,N
AU  - Wilson,M
AU  - Pearson,O
AU  - Jones,J
AU  - Overell,J
EP  - 100
PB  - SAGE PUBLICATIONS LTD
PY  - 2018///
SN  - 1352-4585
SP  - 99
TI  - Alemtuzumab after natalizumab SWitch in evolving rapidly severe multiple sclerosis (ANSWERS MS): long-term UK & Ireland experience.
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446861400151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download